β-Blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal titleEuropean journal of emergency medicine : official journal of the European Society for Emergency Medicine
Publication Begin page150
Publication End page4
MetadataShow full item record
AbstractThis is a systematic review of the literature to compare the efficacy of calcium channel blockers to β-blockers for acute rate control of atrial fibrillation with rapid ventricular response in the emergency department setting. PubMed, EMBASE, and the Cochrane Registry were searched. Relative risk (95% confidence interval) was calculated between drugs and methodological quality of included studies was evaluated. Of the 1003 studies yielded by our initial search, two met inclusion criteria and provided sufficient data. These were randomized double-blinded studies (n=92) comparing intravenous diltiazem with intravenous metoprolol. The combined relative risk of acute rate control by diltiazem versus metoprolol was 1.8 (95% confidence interval 1.2-2.6). On the basis of the paucity of available evidence, diltiazem may be more effective than metoprolol in achieving rapid rate control, but high-quality randomized studies are needed.
CitationMartindale JL, deSouza IS, Silverberg M, Freedman J, Sinert R. β-Blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review. Eur J Emerg Med. 2015 Jun;22(3):150-4. doi: 10.1097/MEJ.0000000000000227. PMID: 25564459.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Dilemmas in the acute pharmacologic treatment of uncontrolled atrial fibrillation.
- Authors: Elam K, Bolar-Softich KL
- Issue date: 1997 Jul
- The evidence regarding the drugs used for ventricular rate control.
- Authors: Segal JB, McNamara RL, Miller MR, Kim N, Goodman SN, Powe NR, Robinson K, Yu D, Bass EB
- Issue date: 2000 Jan
- Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department.
- Authors: Hines MC, Reed BN, Ivaturi V, Bontempo LJ, Bond MC, Hayes BD
- Issue date: 2016 Dec 15
- Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
- Authors: Corino VD, Ulimoen SR, Enger S, Mainardi LT, Tveit A, Platonov PG
- Issue date: 2015 Feb
- Chronic atrial fibrillation: a systematic review of medical heart rate control management.
- Authors: Nikolaidou T, Channer KS
- Issue date: 2009 Jun